Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease
about
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationvon Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantationIncreased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteriesPlasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris.Is there a menopausal metabolic syndrome?Upright posture and maximal exercise increase platelet aggregability and prostacyclin production in healthy male subjectsThrombin activatable fibrinolysis inhibitor : its role in slow coronary flow.Association between physical activity and endogenous fibrinolysis in peripheral arterial disease: a cross-sectional study.Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone), insulin, coagulation and fibrinolytic factors in men with coronary arteriosclerosis
P2860
Q30415902-8892C515-A5F4-4BAE-AF53-87800DBEBB4CQ33611676-E930363D-BB5C-48EA-BA7F-3FB381057851Q36438240-81AD3758-7946-4DB9-88A9-19FB949DF663Q37131350-78B04500-12F7-412D-B685-2D5496C9C527Q40305997-9A567CF5-6B9B-4622-89F3-C6B53D8DBA31Q40628124-24CA8865-B747-46EF-A510-D074D5AAA35DQ41653555-4E00DD3D-2864-4A43-9B1A-7D4BFA34E153Q42581592-CD7CA054-A1DA-41E6-BB62-8702DB406B92Q44935309-691F3B31-0DA2-44E3-8310-1C6DCAA3F6ACQ53800699-6AE01743-6D41-4138-B905-E00B54813E3AQ54070449-2A985ADA-5227-4EAA-B07E-B1B170BA6A3DQ58282320-BE8D0455-69BE-4F99-96D1-E47AF169AC22
P2860
Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
name
Plasminogen activator inhibito ...... s with coronary artery disease
@ast
Plasminogen activator inhibito ...... s with coronary artery disease
@en
Plasminogen activator inhibito ...... s with coronary artery disease
@nl
type
label
Plasminogen activator inhibito ...... s with coronary artery disease
@ast
Plasminogen activator inhibito ...... s with coronary artery disease
@en
Plasminogen activator inhibito ...... s with coronary artery disease
@nl
prefLabel
Plasminogen activator inhibito ...... s with coronary artery disease
@ast
Plasminogen activator inhibito ...... s with coronary artery disease
@en
Plasminogen activator inhibito ...... s with coronary artery disease
@nl
P2093
P2860
P356
P1476
Plasminogen activator inhibito ...... s with coronary artery disease
@en
P2093
Estellés A
P2860
P304
P356
10.1136/HRT.59.5.535
P577
1988-05-01T00:00:00Z